Rankings
▼
Calendar
ALDX Q4 2019 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ALDX
Aldeyra Therapeutics, Inc.
$290M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$13M
EPS (Diluted)
$-0.45
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$76M
Total Liabilities
$27M
Stockholders' Equity
$48M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$13M
-$11M
-16.2%
Net Income
-$13M
-$11M
-23.8%
← FY 2019
All Quarters
Q1 2020 →